FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Randall Holcombe

Research Profile

Chemicals & Drugs

Disorders

Physiology

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Kestutis Planutis; Mary Pat Moyer; Anthony V Nguyen; Marina Planutiene; Randall F Holcombe
Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.
Thanh H Dellinger; Ramez N Eskander; Danielle D Jandial; Micaela E Martinez; Bradley J Monk; Kestutis Planutis; Xiaolin Zi; Randall F Holcombe
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Micaela Martinez; Edward L Nelson; Nadia Ono; Marina Planutiene; Kestutis Planutis; Randall F Holcombe
Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Randall Holcombe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kestutis Planutis; Mary Pat Moyer; Anthony V Nguyen; Marina Planutiene; Randall F Holcombe
Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.
Journal of translational medicine 2013;11():50.
2012: Thanh H Dellinger; Ramez N Eskander; Danielle D Jandial; Micaela E Martinez; Bradley J Monk; Kestutis Planutis; Xiaolin Zi; Randall F Holcombe
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Gynecologic oncology 2012;126(2):259-67.
2012: Micaela Martinez; Edward L Nelson; Nadia Ono; Marina Planutiene; Kestutis Planutis; Randall F Holcombe
Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.
Cancer cell international 2012;12(1):2.
2011: Marina Planutiene; Kestutis Planutis; Randall F Holcombe
Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion.
Vascular cell 2011;3():28.
2011: Rani Najdi; Randall F Holcombe; Marian L Waterman
Wnt signaling and colon carcinogenesis: beyond APC.
Journal of carcinogenesis 2011;10():5.
2010: Anthony V Nguyen; C Gregory Albers; Randall F Holcombe
Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles.
International journal of molecular medicine 2010;26(1):121-5.
2010: Randall F Holcombe; Krista J Hollinger
Mission-focused, productivity-based model for sustainable support of academic hematology/oncology faculty and divisions.
Journal of oncology practice / American Society of Clinical Oncology 2010;6(2):74-9.
2009: R Najdi; A Syed; L Arce; Heidi Theisen; J-Ht Ting; F Atcha; A V Nguyen; M Martinez; Randall F Holcombe; R A Edwards; J Lawrence Marsh; Marian L Waterman
A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.
Oncogene 2009;28(47):4133-46.
2009: Yaxiong Tang; Anne R Simoneau; Wu Xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F Holcombe; Frances A Jurnak; Dan Mercola; Bang H Hoang; Xiaolin Zi
WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Molecular cancer therapeutics 2009;8(2):458-68.
2009: Anthony V Nguyen; Micaela Martinez; Michael J Stamos; Mary Pat Moyer; Kestutis Planutis; Christopher Hope; Randall F Holcombe
Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer.
Cancer management and research 2009;1():25-37.
2008: Christopher Hope; Kestutis Planutis; Marina Planutiene; Mary Pat Moyer; Karanjodh S Johal; Jaesung Woo; Calista Santoso; Joseph A Hanson; Randall F Holcombe
Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention.
Molecular nutrition & food research 2008;52 Suppl 1():S52-61.
2008: Joann You; Anthony V Nguyen; C Gregory Albers; Fritz Lin; Randall F Holcombe
Wnt pathway-related gene expression in inflammatory bowel disease.
Digestive diseases and sciences 2008;53(4):1013-9.
2008: Kenneth J Chang; John G Lee; Randall F Holcombe; Jeffrey Kuo; Raman Muthusamy; Mark L Wu
Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer.
Nature clinical practice. Gastroenterology & hepatology 2008;5(2):107-11.
2007: X Joann You; Peter J Bryant; Frances Jurnak; Randall F Holcombe
Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease.
Oncology reports 2007;18(3):691-4.
2007: Yi Guo; Xiaolin Zi; Zach Koontz; Alison Kim; Jun Xie; Richard Gorlick; Randall F Holcombe; Bang H Hoang
Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2007;25(7):964-71.
2007: Jason A Zell; Archana Jaiswal McEligot; Argyrios Ziogas; Randall F Holcombe; Hoda Anton-Culver
Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease.
Nutrition and cancer 2007;59(1):36-45.
2007: Kestutis Planutis; Marina Planutiene; Mary Pat Moyer; Anthony V Nguyen; Cherlyn A Pérez; Randall F Holcombe
Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells.
BMC cell biology 2007;8():12.
2007: Sai-Hong Ignatius Ou; Randall F Holcombe
Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
Drugs 2007;67(4):611-2.
2006: Randall F Holcombe
Reengineering the clinical research enterprise: will the new vision for translational and clinical science be successful without more support for mentors?
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2006;54(5):231-4.
2006: Randall F Holcombe; Christine E McLaren; Tatjana Milovanovic
Immunomodulation with low dose levamisole in patients with colonic polyps.
Cancer detection and prevention 2006;30(1):94-8.
2006: Jane Choi; Kevin Kong; Tahseen Mozaffar; Randall F Holcombe
Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer.
Anti-cancer drugs 2006;17(1):103-5.
2005: Xiaolin Zi; Yi Guo; Anne R Simoneau; Christopher Hope; Jun Xie; Randall F Holcombe; Bang H Hoang
Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
Cancer research 2005;65(21):9762-70.
2005: Randall F Holcombe
Viewpoint: who's watching out for the clinical academician?
Academic medicine : journal of the Association of American Medical Colleges 2005;80(10):905-7.
2005: Anthony Nguyen; Andrea Rosner; Tatjana Milovanovic; Christopher Hope; Kestutis Planutis; Baisakhi Saha; Benjaporn Chaiwun; Fritz Lin; S Ashraf Imam; J Lawrence Marsh; Randall F Holcombe
Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
International journal of oncology 2005;27(4):949-56.
2005: T Byun; Misagh Karimi; J Lawrence Marsh; Tatjana Milovanovic; Fritz Lin; Randall F Holcombe
Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis.
Journal of clinical pathology 2005;58(5):515-9.
2004: Tatjana Milovanovic; Kestutis Planutis; Anthony Nguyen; J Lawrence Marsh; Fritz Lin; Christopher Hope; Randall F Holcombe
Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma.
International journal of oncology 2004;25(5):1337-42.
2004: Randall F Holcombe; Kevin M Kong; Donna Wimmer
Combined topoisomerase I inhibition for the treatment of metastatic colon cancer.
Anti-cancer drugs 2004;15(6):569-74.
2003: K Pham; Tatjana Milovanovic; Ronald J Barr; T Truong; Randall F Holcombe
Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.
Molecular pathology : MP 2003;56(5):280-5.
2003: Karen R Sommers; Kevin M Kong; Dang T Bui; John P Fruehauf; Randall F Holcombe
Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine.
Anti-cancer drugs 2003;14(8):659-62.
2003: Randall F Holcombe; Mai Gu; David Imagawa; Tatjana Milovanovic
Expression of Kit and platelet-derived growth factor receptors alpha and beta in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571).
Anti-cancer drugs 2003;14(8):651-7.
2003: Louis A Gottschalk; Randall F Holcombe; D Jackson; Robert J Bechtel
The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients.
Methods and findings in experimental and clinical pharmacology 2003;25(2):117-22.
2002: Randall F Holcombe; J Lawrence Marsh; Marian L Waterman; Fritz Lin; Tatjana Milovanovic; T Truong
Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma.
Molecular pathology : MP 2002;55(4):220-6.
2002: Albert Cerussi; Dorota Jakubowski; Natasha Shah; Frederic Bevilacqua; Ryan Lanning; A J Berger; David Hsiang; John Butler; Randall F Holcombe; Bruce J Tromberg
Spectroscopy enhances the information content of optical mammography.
Journal of biomedical optics 2002;7(1):60-71.
2001: Karine Hovanes; Tony W H Li; Jesus E Munguia; T Truong; Tatjana Milovanovic; J Lawrence Marsh; Randall F Holcombe; Marian L Waterman
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
Nature genetics 2001;28(1):53-7.
2001: Albert Cerussi; A J Berger; Frederic Bevilacqua; Natasha Shah; Dorota Jakubowski; John Butler; Randall F Holcombe; Bruce J Tromberg
Sources of absorption and scattering contrast for near-infrared optical mammography.
Academic radiology 2001;8(3):211-8.
2001: Randall F Holcombe; Tatjana Milovanovic; RM Stewart; T M Brodhag
Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints.
Cancer detection and prevention 2001;25(2):183-91.
1999: Randall F Holcombe; J Jacobson; S R Dakhil; RM Stewart; K S Betzing; K Kannan; J S Macdonald
Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009.
Cancer immunology, immunotherapy : CII 1999;48(9):533-9.
1999: Randall F Holcombe; J Jacobson; A Li; C M Moinpour
Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience.
American journal of clinical oncology 1999;22(1):18-21.
1998: M S Cain; G V Burton; Randall F Holcombe
Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids.
The American journal of the medical sciences 1998;315(3):202-7.
1998: Randall F Holcombe; A Li; RM Stewart
Levamisole and interleukin-2 for advanced malignancy.
Biotherapy (Dordrecht, Netherlands) 1998;11(4):255-8.
1996: K Kannan; R M Stewart; W Bounds; Sven Carlsson; M Fukuda; K W Betzing; Randall F Holcombe
Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium.
Cellular immunology 1996;171(1):10-9.
1996: HJ Berkel; Randall F Holcombe; M Middlebrooks; K Kannan
Nonsteroidal antiinflammatory drugs and colorectal cancer.
Epidemiologic reviews 1996;18(2):205-17.
1995: K Kannan; S G Divers; A A Lurie; Robert Chervenak; M Fukuda; Randall F Holcombe
Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy.
European journal of haematology 1995;55(3):145-51.
1995: S G Divers; K Kannan; R M Stewart; K W Betzing; D Dempsey; M Fukuda; Robert Chervenak; Randall F Holcombe
Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates.
Transfusion 1995;35(4):292-7.
1995: Randall F Holcombe; Bruce Baethge; R E Wolf; K W Betzing; R M Stewart
Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.
Annals of the rheumatic diseases 1995;54(1):69-72.
1994: S W Rypkema; Randall F Holcombe
The role of the hematologist/oncologist as a primary care provider.
The American journal of the medical sciences 1994;308(6):360-4.
1994: W Bounds; K W Betzing; R M Stewart; Randall F Holcombe
Social drinking and the immune response: impairment of lymphokine-activated killer activity.
The American journal of the medical sciences 1994;307(6):391-5.
1994: Randall F Holcombe; R M Stewart; K W Betzing; K Kannan
Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.
Cancer immunology, immunotherapy : CII 1994;38(6):394-8.
1994: Randall F Holcombe; Bruce Baethge; R E Wolf; K W Betzing; R M Stewart; V C Hall; M Fukuda
Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.
Lupus 1994;3(2):97-102.
1994: Randall F Holcombe; K L Jones; R M Stewart
Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoblastoid cell lines and review of the literature.
Immunodeficiency 1994;5(2):131-40.
1993: K H Goodrich; Xavier Alvarez; Randall F Holcombe
Effect of levamisole on major histocompatibility complex class I expression in colorectal and breast carcinoma cell lines.
Cancer 1993;72(1):225-30.
1993: Randall F Holcombe; Bruce Baethge; R M Stewart; K Betzing; V C Hall; M Fukuda; R E Wolf
Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels.
Clinical immunology and immunopathology 1993;67(1):31-9.
1993: Randall F Holcombe; J Griffin
Effect of insurance status on pain medication prescriptions in a hematology/oncology practice.
Southern medical journal 1993;86(2):151-6.
1992: K L Jones; R M Stewart; M Fowler; M Fukuda; Randall F Holcombe
Chediak-Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins.
Clinical immunology and immunopathology 1992;65(3):219-26.
1992: Randall F Holcombe
Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
Acta haematologica 1992;87(1-2):45-8.
1991: Randall F Holcombe; D A Stephenson; A Zweidler; R M Stewart; Verne M Chapman; J G Seidman
Linkage of loci associated with two pigment mutations on mouse chromosome 13.
Genetical research 1991;58(1):41-50.
1991: Randall F Holcombe; P A Treseler; D S Rosenthal
Chronic myelomonocytic leukemia transformation in polycythemia vera.
Leukemia 1991;5(7):606-10.
1990: Randall F Holcombe; R van de Griend; S L Ang; R L Bolhuis; J G Seidman
Gamma-delta T cells in Chediak-Higashi syndrome.
Acta haematologica 1990;83(4):193-7.